[ACCESSWIRE]
Conference to Take Place on Wednesday, February 3 and Thursday, February 4, 2016
NEW YORK, NY / ACCESSWIRE / February 3, 2016 / CITIVA, a leading developer of cannabinoid research studies in numerous countries, including Jamaica and the United States, will take part in The Cannabiz Business and International Investors Conference Jamaica 2016. The Conference has named Josh Stanley as one of its speakers and Josh will be an integral part of the Conference as he explains CITIVA's current research and its impact on the cannabis industry.
Stanley and other CITIVA associates will be available during the conference to speak directly to consumers, researchers and the press about CITIVA's ongoing research. In addition, they will discuss their ongoing support of the medical cannabis industry, and their vision of a licensed partnerships seed-to-sale model.
CITIVA's mission is to advance the science of cannabinoid medicine and improve lives in communities around the world. CITIVA has recently entered into a research partnership with the University of the West Indies, Mona Campus (UWI) and is focused on advancing the study of marijuana and its efficacy in the field of medicine. In July 2015, CITIVA initiated construction at UWI of the world's first facility dedicated to medical marijuana research.
The Conference aims to apprise Jamaicans, international investors and interested parties about the cannabis industry regulatory framework that is to be established in Jamaica, and to allow potential investors to gain a better understanding of the investment climate in Jamaica. In addition, the conference will help to facilitate partnerships between local companies and potential cannabis business operators.
Details are as follows:
WHERE: Jamaica Conference Centre, Kingston (www.nalgjamaica.com)
WHEN: 9:30am to 5:00pm daily
About CITIVA
Founded in 2014 by Josh Stanley and a small group of New York healthcare professionals, CITIVA set a simple yet ambitious goal: to standardize and scientifically prove the therapeutic and clinical effects of cannabinoid medicine.
Stanley, a renowned medical cannabis advocate, witnessed the miraculous effects that cannabis extracts had on epileptic children and many other patients of varying conditions. Thanks to the established team in New York, which includes a dedicated staff of physicians, horticulture experts, medical cannabis advocates, pharmacists, and chemists, CITIVA has a unique capacity to carry out its mission. CITIVA has established a research and development hub at the University of the West Indies, Mona Campus in Kingston, Jamaica, with multiple collaborative human trials planned.
CITIVA is focused on advancing the study of cannabis and its efficacy in the field of medicine. CITIVA's commitment to a well-designed drug development program to investigate cannabinoids will lead to a new field of clinical medicine for conditions such as diabetes, epilepsy, chronic pain, as well as for various mental health disorders.
CONTACT:
Laura Danford Mandel
917-848-1460
laura@ldmpr.com
SOURCE: CITIVA